Article

With blended visio, two different multifocals perform better thanone type, surgeon says

San Francisco-Blended vision with diffractive and refractivemultifocal IOLs offers better visual results in all lightingconditions than bilateral diffractive multifocal technology,explained Henry L. Milne, MD, at the American Society of Cataractand Refractive Surgery annual meeting.

Dr. Milne, a refractive surgeon in Columbia, SC, undertook a study of 52 patients to determine any advantage in terms of vision and patient satisfaction for those receiving the two different lenses compared with those who received the diffractive technology only. Twenty-nine patients received the apodized diffractive IOL (AcrySof ReSTOR, Alcon Laboratories) in one eye and the refractive multifocal IOL (ReZoom, Advanced Medical Optics) in the other. Twenty-three patients received the diffractive technology in each eye.

In the blended vision group, 27 of 29 patients (94%) were completely functional without glasses compared with only 15 of 23 patients (65%) in the diffractive technology group.

The reason that patient satisfaction is so high in the blended vision group is that one lens is performing better than the other in different lighting situations, Dr. Milne said.

"The AcrySof ReSTOR IOL is a very good near lens in bright light and in low light becomes a better distance lens, theoretically," Dr. Milne explained. "The ReZoom multifocal lens is a good intermediate vision lens. It does better up close in lower light and does better at a distance in bright light. So what is one lens' strength is another one's weakness, basically."

The diffractive lens uses +4.0 D of additional power in the lenticular plane for near, which translates into +3.2 D at the spectacle plane. The result is good near vision with materials held close but poorer-quality intermediate vision, which is needed for computer screen use.

On the other hand, the ReZoom multifocal lens has a +3.5-D add at the lenticular plane for near, achieving +2 to +2.25 D at the spectacle plane. This offers better intermediate vision, Dr. Milne explained.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.